Zhengye Biotechnology Holding Limited (ZYBT) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Zhengye Biotechnology Holding Limited (ZYBT) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $41.2M, listed on NASDAQ, employing roughly 278 people, carrying a beta of -2.45 to the broader market. Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. Led by Songlin Song, public since 2025-01-07.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for ZYBT as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →